Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 12:34 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1417–1440 of 1,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ulcerative Clear all

Conditions: Ulcerative Colitis
Interventions: HMPL-004 1800 mg/day, Placebo, HMPL-004 2400 mg/day; Drug
Lead sponsor: Hutchison Medipharma Limited; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Agawam, Massachusetts

Conditions: Diabetic Foot Infection, Non-healing Wound, Non-healing Diabetic Foot Ulcer
Interventions: TTAX01, Standard Care; Biological · Other
Lead sponsor: BioTissue Holdings, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 16
States / cities: San Francisco, California • Sylmar, California • Miami, Florida + 13 more

Conditions: Diabetic Foot
Interventions: Removable cast walker, Irremovable cast walker; Device
Lead sponsor: University of Arizona; Other
Eligibility: 37 Years to 68 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Ulcerative Colitis
Interventions: Herbal treatment (SA100); Drug
Lead sponsor: Stanford University; Other
Eligibility: 13 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Ulcerative Colitis
Interventions: UCRI; Diagnostic Test
Lead sponsor: Glycominds, LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Venous Leg Ulcer
Interventions: DermACELL AWM; Other
Lead sponsor: LifeNet Health; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 7
States / cities: Tucson, Arizona • Fresno, California • Los Angeles, California + 3 more

Conditions: Colitis Ulcerative
Interventions: SAR441566, SAR441566 matching Placebo; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 19
States / cities: Sun City, Arizona • Bristol, Connecticut • Clermont, Florida + 16 more

Conditions: Inflammatory Bowel Disease
Interventions: Breast Milk Sampling, Risankizumab; Procedure · Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Houston, Texas

Conditions: Ulcerative Colitis (Disorder)
Interventions: pomegranate juice -> habitual diet, habitual diet -> pomegranate juice; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Corneal Ulcer
Interventions: Contact lens packaging solution, Balanced salt solution (BSS); Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 38 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Ulcerative Colitis
Interventions: Upadacitinib; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2031
U.S. locations: 20
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Corona, California + 16 more

Conditions: Inflammatory Bowel Diseases
Interventions: cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells; Biological
Lead sponsor: The Foundation for Orthopaedics and Regenerative Medicine; Other
Eligibility: Not listed
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Naples, Florida

Conditions: Pressure Ulcer
Interventions: Optimal Turning, Standard Care Practices, Patient Sensor; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 1,312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Stanford, California

Conditions: Colitis, Ulcerative
Interventions: Placebo, Anti-IP-10 Antibody; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 23
States / cities: La Jolla, California • Santa Monica, California • Wheat Ridge, Colorado + 20 more

Conditions: Pressure Injury
Interventions: Freedom Bed, Group II Low Air Loss/Alternating Pressure Mattress; Device
Lead sponsor: Northeast Center for Rehabilitation and Brain Injury; Other
Eligibility: 14 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Lake Katrine, New York

Conditions: Diabetic Foot Ulcer, Wagner Grade 1 - 2, Chronic Wound, Open Wound
Interventions: ELU42 Topical Spray; Drug
Lead sponsor: Eluciderm Inc; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 4
States / cities: O'Fallon, Illinois • Springfield, Illinois • Oradell, New Jersey + 1 more

Conditions: Wound of Skin
Interventions: Normal Saline and Amorphous gel, BIAKOS™ Antimicrobial Skin & Wound Cleanser, BIAKŌS Antimicrobial Wound Gel; Device
Lead sponsor: SerenaGroup, Inc.; Network
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Pressure Ulcer, Diabetic Foot Ulcer, Venous Leg Ulcer
Interventions: ExufiberAG+; Device
Lead sponsor: Molnlycke Health Care AB; Industry
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 2
States / cities: San Francisco, California • Miamisburg, Ohio

Conditions: Ulcerative Colitis Associated Pouchitis
Interventions: biologically active human fecal microbiota, sigmoidoscopy; Biological · Procedure
Lead sponsor: Virginia O. Shaffer; Other
Eligibility: 18 Years to 65 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Diabetic Foot Ulcer, Offloading
Interventions: Offloading boot: PulseFlow; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Ulcerative Colitis (UC)
Interventions: Not listed
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 8,250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2026
U.S. locations: 170
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 133 more

Conditions: Diabetic Foot Ulcer (DFU)
Interventions: Xcell Amnio Matrix, Standard of Care (SOC); Biological · Drug
Lead sponsor: New Horizon Medical Solutions; Network
Eligibility: 18 Years and older
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 3
States / cities: Fresno, California • San Diego, California • Dallas, Texas

Conditions: Venous Ulcer
Interventions: Coban 2 Layer Compression System; Device
Lead sponsor: Solventum US LLC; Industry
Eligibility: 21 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 5
States / cities: Montgomery, Alabama • Castro Valley, California • Lawrenceville, Georgia + 2 more

Conditions: Ulcerative Colitis
Interventions: Brazikumab Maintenance Dose, Brazikumab Induction Dose; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 10
States / cities: Chula Vista, California • Lancaster, California • Colorado Springs, Colorado + 7 more

Search by objective public record fields.

A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis

Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)

The Association Between Unprotected Standing, Walking and Wound Healing in Diabetes

Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis

Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients.

Clinical Effectiveness of DermACELL AWM in Subjects With Chronic Venous Leg Ulcers

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease

Effects of Pomegranate Juice on Ulcerative Colitis

Studying the Relationship Between Contact Lens Packaging Solutions and Bacterial Binding to Surface Eye Cells

Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Crohn's Disease or Ulcerative Colitis

Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers

Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis

Effectiveness of the Freedom Bed as Compared to Alternating Pressure Mattress in Treatment of Pressure Injuries in Persons With Limited Mobility Due to Traumatic Brain Injury and /or Spinal Cord Injury

Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers

Comparing a Synergistic Antimicrobial Cleanser and Gel to Normal Saline and an Amorphous Gel in Reducing Bioburden and Promoting Healing in Chronic Lower Extremity Ulcers

An Open, Non-comparative, Multicenter Investigation to Evaluate the Safety and Performance of Exufiber Ag+, a Gelling Fiber Silver Dressing, When Used in Medium to High Exuding Chronic Wounds

FMT in Ulcerative Colitis-Associated Pouchitis

Novel Offloading for Diabetic Foot Ulcers With PulseFlow: A Prospective Study

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs

Randomized Controlled 8-week Crossover Evaluation of Compression Bandage Systems for Venous Leg Ulcers

Open-label Extension Study of Brazikumab in Ulcerative Colitis